title: [Visceral leishmaniasis and acute lymphoblastic leukemia B: what is the relationship?].
authors.affiliation: Laboratoire d'Hématologie CHU Hassan II, Fès, Maroc.
authors.forename: Hind
authors.initials: H
authors.lastname: El Youssi
authors.affiliation: Laboratoire d'Hématologie CHU Hassan II, Fès, Maroc.
authors.forename: Aziz
authors.initials: A
authors.lastname: Touaoussa
authors.affiliation: Laboratoire d'Hématologie CHU Hassan II, Fès, Maroc.
authors.forename: Imane
authors.initials: I
authors.lastname: Bergui
authors.affiliation: Laboratoire d'Hématologie CHU Hassan II, Fès, Maroc.
authors.forename: Nawal
authors.initials: N
authors.lastname: Bougrine
authors.affiliation: Laboratoire d'Hématologie CHU Hassan II, Fès, Maroc.
authors.lastname: Moncef
authors.forename: Hassani
authors.initials: H
authors.lastname: Amrani
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002648:Child; D017809:Fatal Outcome; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000469:parasitology*; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D000981:Antiprotozoal Agents
keywords: acute lymphoblastic leukemia; treatment; visceral leishmaniasis